The findings of a new study published in the journal Molecular Neurobiology “support a promising therapeutic profile for CBD as a new fast-acting antidepressant drug.” “Currently available antidepressants have a substantial time lag to induce therapeutic response and a relatively low efficacy”, states the study’s researchers, noting that “The development of drugs that addresses these …
Cannabidiol (CBD), a cannabis compounds, may be useful in treating anxiety-related disorders as well a substance abuse disorders, according to a new study, “[C]annabidiol, the main non-psychotomimetic phytocannabinoid found in Cannabis sativa, reduces anxiety”, states the abstract of the study, published by the British Journal of Pharmacology and the U.S. National Institute of Health. “There is …
New research published by the U.S. National Institute of Health, and published in-print by the journal Behavioural Brain Research, has found that cannabidiol can attenuate catalepsy induced by haloperidol, and can prevent it if taken prior to the use of haloperidol. Catalepsy is a trancelike state marked by loss of voluntary motion, sensations and consciousness …
Cannabidiol has a strong anti-inflammatory effect, and can also improve lung function in those with acute lung injury, indicating that it may be a viable treatment option for inflammatory lung diseases, according to a new study published in the journal Immunopharmacology Immunotoxicology. According to the study; “We have previously shown that the prophylactic treatment with …
A new study published in the International Journal of Neuropsychopharmacology, and published online by the National Institute of Health, has found that cannbinoids may treat panic disorders. “The present study investigated the effects of systemic or intra-dorsolateral periaqueductal gray (dlPAG) administration of CB1 agonists [meant to mimic cannabinoids] on behavioural changes induced in rats by …
